IRIS
ORIO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.968
NA - Nord America 2.600
EU - Europa 2.331
SA - Sud America 466
AF - Africa 107
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.477
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.485
SG - Singapore 1.580
RU - Federazione Russa 1.283
CN - Cina 722
BR - Brasile 384
HK - Hong Kong 256
VN - Vietnam 240
IT - Italia 210
DE - Germania 192
NL - Olanda 144
FI - Finlandia 123
IE - Irlanda 104
SE - Svezia 80
CA - Canada 63
GB - Regno Unito 59
IN - India 40
AR - Argentina 36
CI - Costa d'Avorio 36
MX - Messico 33
UA - Ucraina 32
PL - Polonia 24
ZA - Sudafrica 24
JP - Giappone 21
ES - Italia 20
FR - Francia 19
BD - Bangladesh 18
IQ - Iraq 17
EC - Ecuador 16
TR - Turchia 13
CZ - Repubblica Ceca 11
DZ - Algeria 11
ID - Indonesia 11
LT - Lituania 11
PY - Paraguay 8
BE - Belgio 6
UZ - Uzbekistan 6
CO - Colombia 5
KZ - Kazakistan 5
PK - Pakistan 5
TN - Tunisia 5
DO - Repubblica Dominicana 4
EG - Egitto 4
KE - Kenya 4
SA - Arabia Saudita 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
GE - Georgia 3
JO - Giordania 3
KG - Kirghizistan 3
MA - Marocco 3
MU - Mauritius 3
MW - Malawi 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
TT - Trinidad e Tobago 3
VE - Venezuela 3
AT - Austria 2
AZ - Azerbaigian 2
BH - Bahrain 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
JM - Giamaica 2
KR - Corea 2
LC - Santa Lucia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
RS - Serbia 2
SR - Suriname 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GH - Ghana 1
GM - Gambi 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
MZ - Mozambico 1
PS - Palestinian Territory 1
SK - Slovacchia (Repubblica Slovacca) 1
SO - Somalia 1
TZ - Tanzania 1
Totale 8.476
Salva come PNG Salva come JPEG
Città #
Singapore 688
Moscow 310
Chandler 297
Beijing 275
Hong Kong 256
Ashburn 184
Amsterdam 133
Millbury 133
Santa Clara 105
Princeton 101
Los Angeles 98
Naples 92
Nanjing 88
Ho Chi Minh City 82
Jacksonville 75
Munich 71
New York 52
San Jose 51
Wilmington 49
Boston 48
São Paulo 43
Dallas 41
Dong Ket 40
Buffalo 39
Seattle 37
Nanchang 36
Redondo Beach 36
Hanoi 35
Ottawa 27
The Dalles 27
Des Moines 26
Napoli 26
Helsinki 24
Chicago 21
Mexico City 20
Tokyo 20
Denver 19
Stockholm 19
Atlanta 17
Shenyang 17
Phoenix 16
Turku 16
Warsaw 16
Chennai 15
Orem 15
Tianjin 15
Jiaxing 14
Montreal 14
Falkenstein 13
Hebei 13
Brooklyn 12
Changsha 12
Da Nang 12
Johannesburg 12
London 12
Norwalk 12
Rio de Janeiro 12
Toronto 12
Dublin 11
Poplar 11
Woodbridge 11
Biên Hòa 10
Houston 10
Dearborn 9
Falls Church 9
Frankfurt am Main 9
Boardman 8
Guangzhou 8
Redwood City 8
Rome 8
San Francisco 8
Brno 7
Düsseldorf 7
Kunming 7
Pune 7
Ankara 6
Guayaquil 6
Hefei 6
Hải Dương 6
Nuremberg 6
Shanghai 6
São José do Rio Preto 6
Thái Nguyên 6
Brasília 5
Council Bluffs 5
Curitiba 5
Guarulhos 5
Haiphong 5
Lawrence 5
Milwaukee 5
Washington 5
Yellow Springs 5
Annapolis 4
Goiânia 4
Indiana 4
Jakarta 4
Joinville 4
Madrid 4
Montevideo 4
Porto Alegre 4
Totale 4.274
Salva come PNG Salva come JPEG
Nome #
Lack of electrocardiographic changes in women with polycystic ovary syndrome. 148
Lack of an association between peroxisome proliferator-activated receptor-gamma gene Pro12Ala polymorphism and adiponectin levels in the polycystic ovary syndrome 138
Influence of nutrition on somatotropic axis: Milk consumption in adult individuals with moderate-severe obesity 132
Cardiopulmonary impairment in young women with polycystic ovary syndrome 130
Improvement in endothelial structure and function after metformin treatment in young normal-weight women with polycystic ovary syndrome: results of a 6-month study 125
Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. 125
Obesity, type 2 diabetes mellitus and cardiovascular disease risk: an uptodate in the management of polycystic ovary syndrome 123
Endocrine Aspects of Environmental "Obesogen" Pollutants 119
Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome? 117
Low serum vitamin D-status, air pollution and obesity: A dangerous liaison 116
Calcium and vitamin D supplementation. Myths and realities with regard to cardiovascular risk 116
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial 115
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 113
Lifestyle changes in the management of adulthood and childhood obesity. 111
Screening a coastal population in Southern Italy: iodine deficiency and prevalence of goitre, nutritional aspects and cardiovascular risk factors. 109
Effects of neridronate treatment in elderly women with osteoporosis 108
The increase of leukocytes as a new putative marker of low-grade chronic inflammation and early cardiovascular risk in polycystic ovary syndrome. 108
Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. 108
Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in young women with polycystic ovary syndrome. 105
EFFECTS OF PHYSICAL EXERCISE ON THE FEMALE REPRODUCTIVE SYSTEM. 105
Vitamin D and thyroid disease: To D or not to D? 105
Comment on Krul-Poel et al. Effect of Vitamin D Supplementation on Glycemic Control in Patients With Type 2 Diabetes (SUNNY Trial): A Randomized Placebo-Controlled Trial. Diabetes Care 2015;38:1420-1426 105
Vitamin D and chronic diseases: the current state of the art 105
Evidence for altered adipocyte function in polycystic ovary syndrome 104
Cardiovascular complications of obesity in adolescents 103
Low vitamin D status and obesity: Role of nutritionist 103
Adrenocortical tumors and insulin resistance: What is the first step? 103
Metabolic and cardiovascular consequences of polycystic ovary syndrome 102
Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency 102
Ovarian size and blood flow in women with polycystic ovary syndrome and their correlations with endocrine parameters 101
Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome 101
31. SIX MONTHS OF TREATMENT WITH CABERGOLINE RESTORES SEXUAL POTENCY IN HYPERPROLACTINEMIC MALES. AN OPEN LONGITUDINAL STUDY MONITORING NOCTURNAL PENILE TUMESCENCE. 100
Leuprolide acetate treatment with and without coadministration of tibolone in premenopausal women with menstrual cycle-related irritable bowel syndrome. 100
Insulin-Mediated Diseases: Adrenal Mass and Polycystic Ovary Syndrome 100
Failure of long-term therapy with sodium valproate in Cushing's disease. 99
Endocrinopathies after allogeneic and autologous transplantation of hematopoietic stem cells. 98
Adrenal adenoma and normal androgen levels in a young woman with polycystic ovaries: a case of idiopathic hirsutism? 97
Metabolic and cardiopulmonary effects of detraining after a structured exercise training programme in young PCOS women 97
BsmI vitamin D receptor genotypes influence the efficacy of antiresorptive treatments in postmenopausal osteoporotic women. A 1-year multicenter, randomized and controlled trial 95
THE GOOD AND BAD EFFECTS OF STATINS ON INSULIN SENSITIVITY AND SECRETION. 95
Mechanisms in endocrinology: Vitamin D as a potential contributor in endocrine health and disease 95
Adrenal Mass: Insight Into Pathogenesis and a Common Link With Insulin Resistance 95
Cardiovascular risk in women with polycystic ovary sydrome 94
Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas 94
Endothelial dysfunction in PCOS: role of obesity and adipose hormones 91
The integrity of the Growth Hormone and Insuline-like Growth Factor -1 axis as outcome predictor after Laparoscopic Adjustable Silicone Gastric Banding. 91
Gonadal status in reproductive age women after haematopoietic stem cell transplantation for haematological malignancies 90
Vitamin D and pancreas: The role of sunshine vitamin in the pathogenesis of diabetes mellitus and pancreatic cancer 90
Effect of growth hormone on cardiac function 89
Hypovitaminosis D: a novel risk factor for coronary heart disease in type 2 diabetes? 89
Endocrine disorders during the first year after autologous stem-cell transplant 88
Growth rate and growth hormone response to growth hormone-releasing hormone challenge in slowly growing children during chronic administration of clonidine 87
Gut: A key player in the pathogenesis of type 2 diabetes? 86
The impact of vitamin D deficiency on patients undergoing kidney transplantation: focus on cardiovascular, metabolic, and endocrine outcomes 85
Inflammatory markers and visceral fat are inversely associated with maximal oxygen consumption in women with polycystic ovary syndrome 84
Beneficial effects of a three-month structured exercise training program on cardiopulmonary functional capacity in young women with polycystic ovary syndrome 84
Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome 83
Low 25 (OH) vitamin D levels are associated with autoimmune thyroid disease in polycystic ovary syndrome 83
Water intake keeps type 2 diabetes away? Focus on copeptin 82
Polycystic ovary syndrome (PCOS) trilogy: a translational and clinical review 80
Polycystic ovary syndrome and obesity: non pharmacological approaches 76
Pharmacological activation of the GABAergic system does not affect GH and PRL release in acromegaly 73
Tianeptine, an antiserotoninergic drug, increases GHRH release into the hypophyseal portal blood of the sheep 73
Androgens in polycystic ovary syndrome: the role of exercise and diet 71
Nutrition, inflammation and liver-spleen axis 70
The cardiovascular risk of young women with polycystic ovary syndrome: an observational, analytical, prospective case-control study 67
Preliminary data on effects of metformin on PED/PEA-15 cellular levels in obese women with polycystic ovary syndrome. 65
Cardiovascular complications of obesity 64
Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. 62
Cardiovascular risk in women with polycystic ovary syndrome 62
Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome 62
Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial 62
DAI NUOVI CRITERI DIAGNOSTICI ALLE RECENTI ACQUISIZIONI TERAPEUTICHE DELLA SINDROME DELL’OVAIO POLICISTICO. 61
Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome 60
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 60
Dose reduction and discontinuation of alendronate in postmenopausal osteoporotic women who were receiving estrogen therapy 59
Efficacy of risedronate administration in osteoporotic postmenopausal women affected by inflammatory bowel disease 59
Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome 59
Early carotid atherosclerosis in normotensive severe obese premenopausal women with low DHEA(S). 58
LA SINDROME METABOLICA NELLA SINDROME DELL’OVAIO POLICISTICO: IL RUOLO DELL’ESERCIZIO FISICO. 58
Relationship between heart rate recovery and inflammatory markers in patients with polycystic ovary syndrome: a cross-sectional study 56
STUDY OF HOMOCYSTEINE LEVELS AND C677T POLYMORPHISM OF MTHFR IN YOUNG WOMEN WITH PCOS. 56
Liver-spleen axis, insulin-like growth factor-(IGF)-I axis and fat mass in overweight/obese females. 55
Raloxifene administration in premenopausal women with uterine leiomyomas: a pilot study 53
Structured exercise training programme versus hypocaloric hyperproteic diet in obese polycystic ovary syndrome patients with anovulatory infertility: a 24-week pilot study 52
Could the Mediterranean diet be effective in women with polycystic ovary syndrome? A proof of concept 51
Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study 50
Favourable effects of exercise-based Cardiac Rehabilitation after acute myocardial infarction on left atrial remodeling 50
Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial 50
Impaired cardiopulmonary parameters in young women with polycystic ovary syndrome 48
Relationship between growth hormone/insulin-like growth factor-1 axis integrity and voluntary weight loss after gastric banding surgery for severe obesity. 48
Malattie Ipotalamo Ipofisarie- Tumori ipofisari secernenti 48
Lipid, glucose and homocysteine metabolism in women treated with a GnRH agonist with or without raloxifene 47
Left ventricular remodelling in patients with moderate systolic dysfunction after myocardial infarction: favourable effects of exercise training and predictive role of N-terminal pro-brain natriuretic peptide. 47
Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS) 46
L’esercizio fisico nei soggetti obesi. 43
Current insights into inositol isoforms, mediterranean and ketogenic diets for polycystic ovary syndrome: From bench to bedside 42
Relationships between inflammatory markers, visceral fat and maximal oxygen consumption in women with polycystic ovary syndrome. 41
Ovulation induction in women with polycystic ovary syndrome 41
Polycystic ovary syndrome: an example of obesity-related cardiovascular complication affecting young women 40
Totale 8.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 31.165
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.165
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202172 0 0 0 0 0 0 13 0 9 3 6 41
2021/2022614 5 3 0 6 4 58 2 11 98 28 126 273
2022/2023728 115 64 22 59 81 60 10 55 92 127 35 8
2023/2024486 24 76 118 15 16 38 3 64 3 4 77 48
2024/20252.676 135 132 29 28 50 157 292 170 174 273 1.013 223
2025/20263.206 603 326 528 532 923 223 71 0 0 0 0 0
Totale 8.574